APA (7th ed.) Citation

Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, & Megna M. (2023). Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data. Dove Medical Press.

Chicago Style (17th ed.) Citation

Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, and Megna M. Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Martora F, et al. Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data. Dove Medical Press, 2023.